Tempo Therapeutics Company
Tempo develops materials that are immune stealth, minimally invasive, and precision engineered for regenerative medicine. The company provids materials that evade the typical host immune rejection response to build synthetic tissue hybrids – from skin to bone to heart to brain.
Industry:
BioEngineering
Headquarters:
California, United States
Founded Date:
2014
Register and Claim Ownership